Kathan Griscik

Kathan Griscik has extensive experience in the biopharmaceutical industry, with a focus on global development operations. Starting in 2011, Griscik worked for GSK as a Clinical Development Scientist and later became a Clinical Development Manager. In 2015, Griscik joined PAREXEL International GSK Business Unit as a Project Leader before transitioning to Merck through ExecuPharm as a Clinical Development Scientist. From 2015 to 2019, Griscik worked at PPD as an Associate Director of Project Management and then as a Senior Project Manager. Currently, Griscik holds the position of Director of Global Development Operations at Theravance Biopharma US, Inc.

Kathan Griscik holds a BS degree in Animal Science from North Carolina State University.